What They List
- Psilocybin Clinical Trial
- Study Screening Information
- Research Participation Details
Research
NCT06299319 - Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD
Clinical Trial in Toronto, Ontario
Psilocybin, the chemical component of "magic mushrooms", has been administered with psychotherapy in several randomized clinical trials (RCTs) showing large and sustained antidepressant effects. There is interest to see if similar effects may be provided in those with obsessive compulsive disorder (OCD). The purpose of this study is to evaluate the safety, feasibility, and clinical effects of psilocybin administra... Source record lists lead sponsor Centre for Addiction and Mental Health and overall status Enrolling By Invitation.
Clinical TrialResearch
Directory Facts
- Status
- Verified from official/source records
- Price
- Free study screening / research participation
- Hours
- Verify with provider
- License / Record
- NCT06299319
- Last Verified
- 2026-06-12
Location
Centre for Addiction and Mental Health, Toronto, Ontario
Source Notes
Discovery row generated from the official ClinicalTrials.gov API record for NCT06299319; status Enrolling By Invitation; sponsor Centre for Addiction and Mental Health.
Source: https://clinicaltrials.gov/study/NCT06299319
MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.